P

Protagonist Therapeutics
D

PTGX

81.840
USD
2.23
(2.80%)
مغلق
حجم التداول
39,759
الربح لكل سهم
3
العائد الربحي
-
P/E
124
حجم السوق
5,116,282,105
أصول ذات صلة المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.